Restructuring watch
Restructuring watch
| Restructuring watch | ||||||
| No fewer than nine public biotech companies cut staff in the fourth quarter, down from 13 in the same period last year. (A) Net loss for 1H05; (B) Operating loss for 1H05; (C) 12-month loss through June 30, 2005; (D) Profitable; Cash and |
